The three major U.S. indices, namely, the Dow Jones Industrial Average, the S&P 500 and the Nasdaq began the thanksgiving week on a bright note, courtesy encouraging vaccine data from AstraZeneca AZN and the University of Oxford.
The AstraZeneca-University of Oxford vaccine has shown 90% effectiveness. Notably, in late stage trials, vaccines developed by Pfizer and its German partner BioNTech have been found 95% effective, while Moderna’s shot is 94.5% effective. Meanwhile, Regeneron’s COVID-19 antibody treatment received emergency use authorization from the FDA.
The positive development on the vaccine front is great news for the United States, which has been seeing rising number of COVID-19 cases over the past few weeks. According to John Hopkins University data, more than 12 million people have been infected in the United States, with the death toll hitting 257,701 as of Nov 23.
Per a Reuters report, Dr. Moncef Slaoui, chief scientific adviser for